About China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H
Clinical Trials at China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H
During the past decade, China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H
According to Clinical.Site data, the most researched conditions in "China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H" are
"Healthy Volunteers" (1 trials), "Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)" (1 trials), "Squamous Cell Carcinoma of Head and Neck" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H" in a lesser frequency.
Clinical Trials Intervention Types at China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H
Most popular intervention types in "China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Placebo" (2 trials), "Cyclophosphamide" (1 trials), "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials) and "PEG-IFN alfa-2a BA-free formulation (Test)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H
The vast majority of trials in "China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H" are
4 trials for "All" genders.
Clinical Trials Status at China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H
Currently, there are NaN active trials in "China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in China Medical University Hospital;Oncology and Hematology Office Critical Care Center, 14H, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".